TrialLancet (London, England)2022

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.

Boon H Chua et al.PubMed ↗Publisher ↗

No numbers read from the abstract.